Review article: The effect of Helicobacter pylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 16, Issue 1, 2002, Pages 34-39

  Laine, L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; FAMOTIDINE; IBUPROFEN; MISOPROSTOL; NAPROXEN; OMEPRAZOLE; PLACEBO; RANITIDINE; ROFECOXIB;

CELL INFILTRATION; DIGESTIVE SYSTEM INJURY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG INDUCED DISEASE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; INTESTINE INJURY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH MUCOSA INJURY; STOMACH ULCER; UPPER GASTROINTESTINAL TRACT; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTIC ULCER; GASTRITIS; GASTROINTESTINAL TOXICITY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STOMACH EROSION; STOMACH HEMORRHAGE; UPPER GASTROINTESTINAL BLEEDING; UPPER GASTROINTESTINAL TRACT INJURY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER;

EID: 0036512373     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. MacDonald WC. Correlation of mucosal histology and aspirin intake in chronic gastric ulcer. Gastroenterology 1973; 65: 381-9.
2. Laine L, Marin-Sorensen M, Weinstein WM. Nonsteroidal anti-inflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992; 87: 1398-402.
3. Shallcross TM, Rathbone BJ, Wyatt JI, Heatley RV. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 1990; 4: 515-22.
4. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992: 102: 1899-905.
5. Laine L, Weinstein WM. The histology of alcoholic hemorrhagic 'gastritis': a prospective evaluation. Gastroenterology 1988; 94: 1254-62.
6. Laine L, Weinstein WM. The histology of erosive 'gastritis' in alcoholic patients: a prospective study. Gastroenterology 1987; 92: 1488.
7. Laine L, Marin-Sorensen M, Weinstein WM. The histology of gastric erosions in patients taking non-stcroidal anti-inflammatory drugs (NSAIDs): a prospective study. Gastroenterology 1988; 94: A247[abstract].
8. Laine L, Cominelli F, Sloane R, Casini-Raggi V, Marin-Sorensen M, Weinstein W. The interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial. Aliment Pharmacol Ther 1995; 9: 127-35.
9. Thillainayagam AV, Tabaqchali S, Warrington SJ, Farthing MJG. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease: a prospective study in healthy volunteers. Dig Dis Sci 1994; 39: 1085-9.
10. Kim JG, Graham DY. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994; 89: 203-7.
11. Goggin PM, Collins DA, Jazrawi RP, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 1993; 34: 1677-80.
12. Lanza FL, Evans DG, Graham DY. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol 1991; 86: 735-7.
13. Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users: response to omeprazole dual therapy. Gut 1996; 39: 22-6.
14. Laine L, Hawkey C, Harper S, et al. No evidence of H. pylori-NSAID interaction in ulcer formation: results of double-blind, placebo-controlled trials. Gastroenterology 1999; 116: A228 [abstract].
15. Taha AS, Dahill S, Morran C, et al. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 1999; 116: 254-8.
16. Taha AS, Sturrock RD, Russell RI. Mucosal erosions in long-term non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut 1995; 36: 334-6.
17. Chan FKL, Sung JJY, Chung SCS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal antiinflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
18. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antiinflammatory drugs. N Engl J Med 1998; 338: 719-26.
19. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with non-steroidal antiinflammatory drugs. N Engl J Med 1998; 338: 727-34.
20. Hawkey CJ, Swannell AJ, Yeomans ND, Langstrom G, Lofberg I, Taure E. Site specific ulcer relapse in non steroidal anti inflammatory drug (NSAID) users: improved prognosis with H. pylori and with omeprazole compared to misoprostol. Gut 1996; 39(Suppl. 3): A149 [abstract].
21. Hawkey CJ, Tulassay Z, Szczepanski L, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998; 352: 1016-21.
22. Agrawal NM, Campbell DR, Safdi MA, Lukasik NL, Huang B, Haber MM. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group. Arch Intern Med 2000; 160: 1455-61.
23. Chan FK, Sung JJ, Suen R, et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? a prospective randomized study. Aliment Pharmacol Ther 1998; 12: 1201-5.
24. Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-73.
25. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K. Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case control study. Gastroenterology 1999; 116: 1305-9.
26. Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997; 42: 586-91.
27. Cullen DJE, Hawkey GM, Greenwork DC, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997; 41: 459-62.
28. Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1998; 33: 234-7.
29. Labenz J, Peitz U, Kohl H, et al. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study. Ital J Gastroenterol Hepatol 1999; 31: 110-5.
30. Santolaria S, Lanas A, Benito R, Perez-Aisa MA, Montoro M, Sainz R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID use. Aliment Pharmacol Ther 1999; 13: 1511-8.
31. Lanas A, Fuentes J, Benito R, Bajador E, Serrano P, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low dose aspirin. Gastroenterology 2000; 118: A252 [abstract].